Official recall notice

FDA DrugClass IINotable

FDA Recall: NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella

Recall date
2026-05-13
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Chemical contamination; presence of lead and lithium above specification

Recommended action

What to do

6,336 bottles

Product description

Chemical contamination; presence of lead and lithium above specification

Verify with the official notice →
Share:

Related Recalls

2026-10-01 · FDA_DRUG
FDA Recall: Greewich: Glutathione Injection
Greewich
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 20 mg per 4 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 15 mg per 3 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC
2026-09-23 · FDA_DRUG
FDA Recall: Fluphenazine HCl Elixir, USP, 10 mg per 2 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volu
Safecor Health, LLC